SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-22-027795
Filing Date
2022-08-03
Accepted
2022-08-03 16:37:32
Documents
68
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q imra-10q_20220630.htm   iXBRL 10-Q 2315139
2 EX-10.4 imra-ex104_233.htm EX-10.4 42660
3 EX-31.1 imra-ex311_7.htm EX-31.1 20740
4 EX-31.2 imra-ex312_9.htm EX-31.2 20971
5 EX-32.1 imra-ex321_6.htm EX-32.1 9846
6 EX-32.2 imra-ex322_8.htm EX-32.2 10040
7 GRAPHIC gscabk25aibx000001.jpg GRAPHIC 157340
  Complete submission text file 0001564590-22-027795.txt   7208092

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA imra-20220630.xsd EX-101.SCH 45322
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE imra-20220630_cal.xml EX-101.CAL 37294
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE imra-20220630_def.xml EX-101.DEF 124561
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE imra-20220630_lab.xml EX-101.LAB 350216
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE imra-20220630_pre.xml EX-101.PRE 260416
62 EXTRACTED XBRL INSTANCE DOCUMENT imra-10q_20220630_htm.xml XML 1084670
Mailing Address 116 HUNTINGTON AVENUE 6TH FLOOR BOSTON MA 02116
Business Address 116 HUNTINGTON AVENUE 6TH FLOOR BOSTON MA 02116 617-206-2020
IMARA Inc. (Filer) CIK: 0001672619 (see all company filings)

IRS No.: 811523849 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39247 | Film No.: 221133225
SIC: 2834 Pharmaceutical Preparations